FINAL Announcement ASMIUA 2021-Blast
FINAL Announcement ASMIUA 2021-Blast
FINAL Announcement ASMIUA 2021-Blast
WELCOME MESSAGE
Message from the President Message from the Chairman
On behalf of the President of the Indonesian Urological Association (IUA), I welcome you to the 44th We hope this message reaches you in good health.
Annual Scientific Meeting of Indonesian Urological Association (ASMIUA) Congress to be held from
1st to 5th September 2021. As concerns increased on the uncertainties and the disruptions caused by The COVID-19 pandemic has been a challenge for almost every aspect of our lives, including the face-
the COVID-19 pandemic, the Organizing Committee has decided to convene it in a virtual conference. to-face congress model. Nothing should stop us from continuous learning and progress especially not
the pandemic. To answer this challenge, The Indonesian Urological Association (IUA) developed a
I would like to extend my warmest welcome to all national and international speakers and participants, virtual conference platform including an interactive industry exhibition that comes as close as possible
as well as our industry partners in joining us. It is indeed a borderless world where knowledge and to the experience of a physical congress. We therefore would like to inform you that the 44th Annual
expertise is concerned and your participation will not only make this meeting a great success but also Scientific Meeting of Indonesian Urological Association (ASMIUA) will be held from September 1st to
more meaningful. I sincerely hope that, all IUA members will continue to contribute and showing support 5th, 2021, in virtual format. The chosen theme is “Urological Science and Services in the Era of Artificial
towards our beloved organization by actively participate in this important meeting. Intelligence”.
I would like to take this opportunity to thank the gallant organizing committee for making this meeting We do hope that in this challenging time, all IUA members will continue to contribute show support
possible and a pleasurable experience. I wish you all great enjoyment of this meeting and much success towards our beloved organization by actively participate in this important meeting.
with your presentations and future collaborations. The scientific committee is currently finalizing an exciting program that will comprise of Oetama lecture,
master classes and main lectures from InaSAU, InaSOU, InaSFFU, InaSTU, InaSE, InaGURS, InaSPU,
We hope you will enjoy the content of the congress, renew old friendships, make new friends, get new InaSRU join sessions between national and international urology societies, courses for residents and a
ideas, and above all, have a good time. special session for the young neurologist. Aside from the scientific program, a memorable IUA Nights
will be also held with prestigious award announcements.
I look forward to seeing you at the 44th ASMIUA-Virtual Congress 2021!
In this wonderful opportunity, we would like to also encourage all IAU members and residents to
participate in highly regarded scientific competition such as educational video, e-poster and oral free
papers. Please submit your abstract(s) and/or video through the congress website www.asmiua2021.
org which the details of the scientific program will be also available.
Wait no more and register soon through the congress website, together, we will bring success for The
44th ASMIUA Congress.
Sincerely regards,
2 3
IMPORTANT DATES COMMITTEE MEMBERS
Deadline for Abstract Submission 15th July 2021 Steering Committee:
Besut Daryanto, MD, PhD
Deadline vote for IUA Award 15th July 2021
Paksi Satyagraha, MD
Deadline for Early Registration 30th July 2021 Ponco Birowo, MD, PhD
UroCle “Tour de ASMIUA 1” 16th - 22nd August 2021 Lukman Hakim, MD, PhD
UroRun 23rd - 29th August 2021
Virtual Conference & Exhibition 1st – 5th September 2021
Chairman:
Taufiq Nur Budaya, MD
Opening Ceremony 2nd September 2021
IUA Night : IUA Award 4th September 2021 Treasurer:
Public Symposium 5 September 2021
th Pradana Nurhadi, MD
Closing Ceremony 5th September 2021
Secretary:
Pande Made Wisnu Tirtayasa, MD, PhD
Scientific:
IMPORTANT CONTACT DETAILS Gerhard Reinaldi Situmorang, MD, PhD
Moh. Ayodhia Soebadi, MD, PhD
SECRETARIAT OF ASMIUA 2021 Widi Atmoko, MD
Ms. Evi Dearny
Kompleks Perkantoran Duta Merlin Blok C / 35 Event:
Jl. Gajah Mada 3 – 5, Jakarta 10130 Prahara Yuri, MD
Phone : +62 – 21 6386 9502 Anggana Suryatmana, MD
Fax : +62 – 21 6386 9503 / 6386 9505 Dyandra Parikesit, MD
Email : asmiua2021@pharma-pro.com
Mobile Phone : +62-811-101-8517 Fund Raiser:
Website : www.asmiua2021.org Pradana Nurhadi, MD
Indrawarman Soeroharjo, MD
Official Virtual Exhibition: Ricky Adriansjah, MD
JINGGA PRO UTAMA (JINGGA) Exhibition Contractor
Mr. Rahmanto Publication & Documentation:
Email : info@jingga-id.com/rahmanto@jingga-id.com Eldien Muhammad Shidqy, MD
Phone : +62 – 21 6386 9502 ext. 311 Mustafa, MD
Fax : +62 – 21 6386 9503 /05
Mobile Phone : Mr. Rahmanto +62-857-1061-0609/ Ms. Mery +62 813-1516-5747
Address : Komp.Duta Merlin Blok C- 35
Secretariat:
Apit
Jl. Gajah Mada 3 – 5 Jakarta 10130, Indonesia
Siwi
MCO® PT. Pharma-Pro International
Managed by PT. PHARMA-PRO INTERNATIONAL
MCO is certified by Indonesia Authority of MICE Industry
Kompleks Perkantoran Duta Merlin Blok C / 35
Jl. Gajah Mada 3 – 5, Jakarta 10130
Phone : +62 – 21 6386 9502
Fax : +62 – 21 6386 9503 / 6386 9505
Email : info@pharma-pro.com
Website : www.pharma-pro.com
MCO is register trademark of PT. Pharma – Pro International
This name is protected by Indonesia copyright laws
4 5
FACULTY MEMBERS FACULTY MEMBERS
International Faculties National Faculties
1. Prof. Axel Merseburger (Germany) 1. Prof. Akmal Taher, MD, PhD 36. Jupiter Sibarani, MD, PhD
2. Prof. Bhaskar Somani, MD (UK) 2. Prof. Chaidir Arif Mochtar, MD, PhD 37. Kadek Budi Santosa, MD, PhD
3. Prof. Guido Giusti, MD, PhD(Italy) 3. Prof. Doddy M. Soebadi, MD, PhD 38. Kuncoro Adi, MD
4. Prof. Igor Vaz (Mozambique) 4. Prof. Harrina Erlianti Rahardjo, MD, PhD 39. Kurnia Penta Seputra, MD
5. Prof. John S. Wiener, MD (USA) 5. Prof. Rainy Umbas, MD, PhD 40. Lukman Hakim, MD, PhD
6. Prof. Jun Miki, MD (Japan) 6. Aaron Tigor Sihombing, MD, PhD 41. Moh. Ayodhia Soebadi, MD, PhD
7. Prof. Olivier Traxer, MD (France) 7. Achmad Rizky Herda Pratama, MD 42. Muhammad Asykar Palinrungi, MD
8. Ali Gözen, MD (Germany) 8. Aga Parardya, MD 43. Nanda Daniswara, MD
9. Anna Lawrence, MD (New Zealand) 9. Agus Rizal A.H. Hamid, MD, PhD 44. Ni Made Hustrini, MD, PhD
10. Asif Muneer, MD (UK) 10. Ahmad Zulfan Hendri, MD 45. Nur Rasyid, MD, PhD
11. Bassem S Wadie, MD (Egypt) 11. Andri Prawata 46. Octoveryal Aslim, MD
12. Eddie Chan, MD ( Hong Kong) 12. Andy Ardiansyah, MD 47. Paksi Satyagraha MD
13. Hirotsugu Uemura, MD, PhD (Japan) 13. Anugrah Dianfitriani Santoso, MD, PhD 48. Pande Made Wisnu Tirtayasa MD, PhD
14. HoYee Tiong, MD (Singapore) 14. Ardy Santosa, MD 49. Pandu Ishaq, MD
15. Hussain Alnajjar, MD (UK) 15. Arry Rodjani, MD 50. Ponco Birowo, MD, PhD
16. James A. Simon, MD (USA) 16. Badai Bhatara Tiksnadi, MD 51. Poppy Desra S Nasution, MD
17. Janak Desai, MD (India) 17. Bambang S. Noegroho, MD, PhD 52. Pradana Nurhadi, MD
18. Jeremy Teoh, MD (Hong Kong) 18. Besut Daryanto, MD, PhD 53. Prahara Yuri, MD
19. Jose Benito A Abraham, MD (Philippine) 19. Boyke Soebhali, MD 54. Putu Moda Arsana, MD
20. Juan Gómez Rivas, MD, PhD (Spain) 20. Didit Pramuditho, MD, PhD 55. Ricky Adriansjah, MD
21. Kandarp Parikh, MD (India) 21. Doddy W. Hami Seno, MD 56. Ricky Agave Ompusunggu, MD
22. Kasra Saeb-Parsy, MD (UK) 22. Donny Eka Putra, MD 57. Safendra Siregar, MD, PhD
23. Ming Liu, MD (China) 23. Dyandra Parikesit, MD 58. Syamsu Hudaya, MD
24. Neil Sheerin, MD, PhD (UK) 24. Etriyel Myh, MD, PhD 59. Syah Mirsya Warli, MD
25. Peter Black, MD (Canada) 25. Ferry Safriadi, MD, PhD 60. Sylvia Detri Elvira, MD
26. Reynaldo Gómez, MD (Chile) 26. Fikri Rizaldi, MD 61. Tanaya Ghinorawa, MD
27. Samuel Vincent G. Yrastorza, MD (Philippine) 27. Fina Widia, MD 62. Tarmono, MD, PhD
28. Sanjay B. Kulkarni,MD (India) 28. Gampo Alam Irdam, MD 63. Taufiq Nur Budaya, MD
29. Siti Nur Masyithah binti Ma’arof, MD (Malaysia) 29. Gede Wirya Kusuma Duarsa MD, MSc, PhD 64. Tjahjodjati, MD, PhD
30. Takaaki Inoue, MD (Japan) 30. Gerhard Reinaldi Situmorang, MD, PhD 65. Vicky Ferdian, MD
31. Tran Toan, MD (Vietnam) 31. I Wayan Yudiana, MD 66. Wahjoe Djatisoesanto, MD
32. Warren Snodgrass, MD (USA 32. Indrawarman Soeroharjo, MD 67. Widi Atmoko, MD
33. Irfan Wahyudi, MD, PhD 68. Yacobda Hamonangan Sigumonrong, MD
34. Johan Renaldo, MD 69. Yevri Zulfiqar, MD, PhD
35. Jufriady Ismy, MD, PhD
6 7
PROGRAM AT A GLANCE
ASMIUA 2021 ASMIUA 2021
Program at Glance Program at Glance
September 1st September 2nd September 3rd September 4th September 5th
Time
WEDNESDAY THURSDAY FRIDAY SATURDAY SUNDAY
WIB (UTC +7)
ROOM
Main room ROOM A ROOM B ROOM C Main room ROOM A ROOM B Main room ROOM A Room B Main room ROOM A ROOM B Main room ROOM A
B
08.00 - 08.30
IUA - INASFU
08.30 - 09.00 IUA - INASPU - AUA Oral Joint Public
Joint Session Presentation Session Symposium
09.00 - 09.30
09.30 - 10.00 Break
Sponsored
Sponsored symposium
11.30 - 12.00 Symposium
Sponsored
13.00 - 13.30 Symposium IUA - INASAU - BAUS
Joint Session
13.30 - 14.00
Sponsored
Symposium
14.00 - 14.30
Sponsored
MASTERCLASS MASTERCLASS MASTERCLASS INASE INASTU INAGURS
Symposium Closing Section
: INASAU : INASOU : INASFFU LECTURE LECTURE LECTURE IUA - INASE - EAU
14.30 - 15.00 Joint Session
15.00 - 15.30 Opening
Sponsored symposium
IUA -INASE- Sponsored Symposium
15.30 - 16.00 Oetama Lecture Break
AUSTEG
COURSE
Sponsored Symposium
16.00 - 16.30 Break Sponsored Symposium
Young Indonesian
INASPU
Urologist College of
16.30 - 17.00 LECTURE
Session Urology
17.00 - 17.30 MASTERCLASS MASTERCLASS MASTERCLASS INASAU INASOU INASFFU
: INASTU : INASE : INAGURS LECTURE LECTURE LECTURE Sponsored Symposium
17.30 - 18.00
Break
18.00 - 18.30 Break Break Break
Sponsored symposium Sponsored symposium Sponsored Symposium
18.30 - 19.00
Moderator: Boyke
Soebhali, MD
Muhammad Asykar
19.00 - 19.05 Opening Palinrungi, MD
Pradana Nurhadi, MD
Muhammad Asykar
20.45 - 21.00 Panel Discussion Palinrungi, MD
Pradana Nurhadi, MD
12 13
DAY 2
SEPTEMBER 2ND 2021
MAIN ROOM ROOM A ROOM B
TIME TOPIC SPEAKER TIME TOPIC SPEAKER TIME TOPIC SPEAKER
15.00 - 15.30 OPENING
15.30 - 15.35 Opening OETAMA LECTURE Besut Daryanto, MD, PhD
14.00 - 14.05 Opening Doddy W. Hami Seno, MD 14.00 - 14.05 Opening Prof. Doddy M. Soebadi, MD, PhD 14.00 - 14.05 Opening Nanda Daniswara, MD
How to Properly Select The Laser Energy for Extending Graft Survival; What The Neil Sheerin, MD, PhD What General Urologists Must Know of Guidelines for Reynaldo Gómez, MD
14.05 - 14.20 Paksi Satyagraha, MD 14.05 - 14.25 14.05 - 14.25
Urological Procedure? Surgeons Need to Know (UK) Urethral Stricture Management (Chile)
Current Trends in Artificial Intelligence Prof. Bhaskar Somani, MD Strategies to Increase Access to Endoscopic Management vs Urethroplasty for Urethral
14.35 - 14.50 14.45 - 15.05 Nur Rasyid, MD, PhD 14.45 - 15.05 Moh. Ayodhia Soebadi, MD, PhD
Application for Endourology (UK) Kidney Transplant in Indonesia Stricture
15.30 - 15.50 Medical Expulsion Therapy in Urinary Tract Stone Ponco Birowo, MD, PhD
Moderator:
Besut Daryanto, MD, PhD
16 17
DAY 3
SEPTEMBER 3RD 2021
SPONSORED SYMPOSIUM TAKEDA
Moderator: Besut Daryanto,
MD, PhD
18 19
DAY 4
SEPTEMBER 4TH 2021
MAIN ROOM ROOM A ROOM B
TIME TOPIC SPEAKER TIME TOPIC SPEAKER TIME TOPIC SPEAKER
IUA-INASPU-AUA JOINT SESSION
Ardy Santosa, MD
08.00 - 08.05 Opening
Johan Renaldo, MD
Warren Snodgrass, MD
08.05 - 08.25 Tubularized Plate Incision (TIP): How I Do It
(USA)
09.00 - 09.15 Dorsal Inlay Graft Gede Wirya Duarsa, MD, PhD
09.15 - 09.30 Glandular Urethral Disassembly (GUD) Irfan Wahyudi, MD, PhD
09.30 - 09.45 Slit Like Adjusted Mathieu (SLAM) Safendra Siregar, MD, PhD
Ardy Santosa, MD
09.45 - 09.55 Discussion
Johan Renaldo, MD
10.00 - 10.05 Opening and Introduction Ahmad Zulfan Hendri, MD 10.00 - 10.05 Opening Besut Daryanto, MD, PhD
10.25 - 10.45 TURB : How Ideal We Have to Perform Jeremy Teoh, MD, (Hong Kong) 10.25 - 10.45 Pediatric Kidney Transplantation; Current Updates Gerhard Reinaldi Situmorang, MD, PhD
11.05 - 11.15 Discussion 11.10 - 11.15 Discussion Besut Daryanto, MD, PhD
5ARI and Alpha-Blocker Combination: Impact on Sexual Function of Prof. Doddy M. Soebadi MD,
11.35 - 11.55
BPH Patients PhD
20 21
DAY 4
SEPTEMBER 4TH 2021
13.00 - 13.45 SPONSORED SYMPOSIUM ZUELLIG
Comprehensive Treatment of Erectile Dysfunction in all Aspects of
Moderator: Fikri Rizaldi, MD
Urological Disease.
13.00 - 13.20 Choosing the Right Pill for ED Treatment: OAD vs On Demand Nur Rasyid, MD, PhD
13.20 - 13.40 Restoring Sexual Function After Prostate Surgery Agus Rizal A.H. Hamid, MD, PhD
13.40 - 13.45 Discussion
SPONSORED SYMPOSIUM J & J
Moderator:
Syah Mirsya Warli, MD
13.45 - 14.05 New Treatment to Pushback Disease Progression in mCSPC Prof. Rainy Umbas, MD, PhD
14.05 - 14.25 Case Sharing Apalutamide in mCSPC Lukman Hakim, MD, PhD
14.25 - 14.30 Discussion
Simultaneous Bilateral Endoscopic Stone Surgery (SBES): Is it Prof. Guido Giusti, MD, PhD
14.50 - 15.10 Goserelin Acetate: Treatment Solution for 3 Stages of Prostate Cancer Syamsu Hudaya, MD 14.55 - 15.15
a safe and Effective Strategy? (Italy)
Moderator:
Opening
Besut Daryanto, MD, PhD
How Importance is Hormone Sensitive?
16.00 - 16.20 Ferry Safriadi, MD, PhD
The Journey to Delay Resistance
16.20 - 16.40 Metastatic Free Survival: The Current Armamentarium Agus Rizal A.H. Hamid, MD, PhD
16.40 -17.00 Managing Final Stage: Real Wold Evidence Prof. Rainy Umbas, MD, PhD
Prof. Doddy M. Soebadi, MD,
17.00 - 17.20 LUTS-BPH Complexities in Men
PhD
17.20 - 17.40 Discussion
17.40 - 18.30 BREAK
Mega Lifesciences session
Moderator: Besut Daryanto, MD,
18.45 – 19.00
PhD
Abiraterone Acetate: Treatment Solution for Metastatic Prostate
Prof. Rainy Umbas, MD, PhD
Cancer
IUA NIGHT-IUA AWARD
22 23
DAY 5
SEPTEMBER 5TH 2021
MAIN ROOM ROOM A
TIME TOPIC SPEAKER TIME TOPIC SPEAKER
IUA - INASFFU - ISSWSH JOINT SESSION
08.00 - 08.05 Opening Poppy Desra S Nasution, MD
08.05 - 08.25 Sexual Dysfunction in Women James A. Simon, MD (USA)
08.25 - 08.45 The impact of LUTS on Female Sexual Function Prof. Harrina Erlianti Rahardjo, MD, PhD
08.45 - 09.05 Psychological Aspect of Female Sexual Function and Dysfunction Sylvia Detri Elvira, MD
11.00 - 11.20 Urinary Tract Infection Management in Era of Antibiotic Resistance Prof. Harrina Erlianti Rahardjo, MD, PhD
11.20 - 11.30 Discussion
SPONSORED SYMPOSIUM MSD
A new hope for Advanced RCC with Immunotherapy Moderator: Aaron Tigor Sihombing, MD, PhD
11.30 - 11.50 Deep Dive into the Management of mRCC Prof. Rainy Umbas, MD, PhD
The Adverse Events of Immunotherapy - What to Know and How to
11.50 - 12.10 Lukman Hakim, MD, PhD
Manage
12.10 - 12.15 Discussion
12.15 - 12.30 BREAK
IUA - INASAU - BAUS JOINT SESSION
12.55 - 13.15 Penile Reconstruction in Latrogenic Injections into the Penis Boyke Soebhali, MD
13.15 - 13.35 The Role of Glans Resurfacing in Penile Cancer Hussain Alnajjar, MD (UK)
Closing remarks
24 25
GENERAL INFORMATION ABSTRACT GUIDELINES
EVENT NAME : 44th ANNUAL SCIENTIFIC MEETING OF INDONESIAN UROLOGICAL Abstract Submission Rules and Regulations
ASSOCIATION (ASMIUA) Virtual Conference and Exhibition (VIRCONEX) Applied for Oral Free Paper, Poster Free Paper and Video Session.
Special attention to Video Session presenter: you only require to submit the abstract (not the video).
THEME : Urological Science and Services in the Era of Artificial Intelligence
Before submitting the abstract, you are requested to carefully read the rules regarding abstract
DATE : 1st - 5th September 2021 submission.
• Abstract(s) may not have been published previously at the time of presentation of the ASMIUA
LANGUAGE : English in the official of the conference and will be used for presentation and congress.
discussion • Any human experimentation that has been conducted with respect to the submitted abstract(s),
should have been conducted according to the protocol approved by the institutional or local
VIRTUAL EXHIBITION : The committee will organized an virtual exhibition in conjunction with the committee on ethics in human investigation; or, if no such committee exists, the works should have
congress, featuring the latest pharmaceutical and medical equipment for been conducted in accordance with the principles of the Declaration of Helsinki of World Medical
clinical managements and research. Companies interested in participating in Association. Council may enquire further into ethical aspects when evaluating the abstract(s).
the exhibition may request for details from the congress secretariat. • All research involving human and animal subjects require ethical clearance. The IRB number should
be declared.
• In clinical studies, the authors must state that an Ethical Committee approval has been obtained.
• Copyright of the abstract(s) is assigned to the Indonesian Urological Association any conflicts with
any other scientific association will be the sole responsibility of the author(s).
• All abstracts that are published, including figures and tables, are the property of Indonesian Urological
Association and are protected by copyright. Requests for reuse of material can be done through.
• The 44th ASMIUA Scientific Committee office reserves the right to obtain your raw data for statistical
evaluation.
Abstract Guidelines
• All abstract(s) must be submitted in English. Applies also for the title, text body and author affiliations
• Only abstract submitted through the website congress or congress email will be considered
• Cancellation or name changes should be notified 1 month prior to the congress by email to
asmiua2021@pharma-pro.com
• Systematic reviews (with or without meta-analysis) can be submitted only when they meet the
following standards :
• The clinical question was clearly defined using a standard PICO (Population, Intervention,
Comparison and Outcome) format
• A comprehensive systematic literature search was carried out
• An assessment of the risk of bias was made
• Key findings are clearly described including clinical practice relevance
Authorship
Each quoted author should have contributed substantially to the represented work in terms of conceptual
design or analysis writing of article and final approval of the article in order to take public responsibility
for the content.
Size
The size of abstracts not more than 300 words and limited to 3,000 characters (including title, body of
abstract, spaces tables and graphics). Every picture / graphic count for 500 characters.
Title
The title should clearly define the topic. Do not identify your institution in the title. There is no maximum
length for the title. However, the characters in the title are included in your total character count. The
first letter of the title will automatically begin with a capital letter. Do type the abstract and title in small
letters, except for abbreviations. Do not type the abstract title in capital letters.
26 27
MODERATED ORAL PRESENTATION
ABSTRACT GUIDELINES GUIDELINE
Authors Description
Type full family name and first name of all authors, only omitting any titles, degrees and institutional Selected from 10 abstracts with the highest score. Authors are required to present their study using
affiliations. It is advisable to check the correct spelling of the family name and initials with each author. presentation form. QnA by the judges will be followed afterward.
Please check that for authors from the same institution, the name of institution is written in the exact
same way to avoid the creation of extra affiliations, which are in fact identical. General Rules
• Participant is required to present their study in the form of presentation (i.e PowerPoint)
Affiliation • The presentation video should be pre-recorded with a duration no longer than 7 minutes
Type the name of the institution, department, city and country in English. • Total presentation length is 10 minutes (pre-recorded presentation 7 minutes, Live Q&A 3 minutes
and standby during the session).
Body of the abstract • Should there be a video (i.e operation video), it can be presented as long as it does not exceed the
The following headings have already been formatted for you and should not be entered in the text fields maximum duration of pre-recorded video
again: • Presentation and QnA session should be in English
• Introduction & objectives • ASMIUA’s presentation template may be used for the presentation
• Materials & methods • Registration to ASMIUA is compulsory for the participants. Registration fee will be exempted for the
• Results presenter (free).
• Conclusion • Please contact secretariat for the free registration
State the objective of the study, describe the material and methods, summarize the results presenting • Failure to comply with the rules will result in disqualification. No exceptions will be granted
sufficient details to support of the conclusions reached (not acceptable to state: “The results will be • Pre-recorded video should be submitted at last on August 25th 2021 by clicking and follow the
discussed”). Use number for numbers and only very well-known abbreviations e.g. kg, MRI etc. If you instruction steps at :
must use other abbreviations, you must explain it the first time it appears. You can use the special keys http://203.77.239.230/submit_video/oral_presentation_asmiua/index.php/auth_peserta
to insert tables, pictures or specific characters. (Email and password VirConEx/Registration)
Proof reading
Verify that your abstract is correct and read the proof carefully that will be automatically shown after you
have inserted all data. Keep a printout for your own records.
MODERATED E-POSTER PRESENTATION GUIDELINE
Editing
Abstract bodies will be published as submitted, except for a simple English spelling check. After Description
submission deadline there is no possibility to edit the abstract anymore. 23 abstracts will be selected as moderated E-Poster. Authors are required to present their study in
traditional one-page landscape E-Poster form. The duration of presentation on this category is shorter
Submission deadline than in oral presentation.
Deadline for abstract submission is July 15th, 2021 at 2PM local time.
In case you want to withdraw your abstract after submission, please send an email before August 1st, General Rules
2021 to asmiua2021@pharma-pro.com • Participant is required to present their study in the form of a poster with added audio talk voiceover
timed that will advance automatically
Submission • The presentation video should be pre-recorded with a duration no longer than 5 minutes. Zoom in
Submit your abstract through congress website www.asmiu2021.org or via congress email asmiua2021@ and zoom out are permissible during presentation.
pharma-pro.com before the deadline. • Total presentation length for moderated E-Poster presentation is 7 minutes (pre-recorded
presentation 5 minutes, Live Q&A 2 minutes and stand by during the session).
Presentation • Should there be a video (i.e operation video), it can be presented as long as it does not exceed the
The scientific committee will give the final decision on the presentation format for each accepted abstract. maximum duration of pre-recorded video
However, presenters are welcome to inform the committee the preference of the presentation format. • Presentation and QnA session should be in English
Please note down at the top of your abstract ONE of the following preferences: ORAL PRESENTATION / • Poster submitted should follow ASMIUA’s E-Poster Guidelines
POSTER PRESENTATION / VIDEO SESSION. • Registration to ASMIUA is compulsory for the participants. Registration fee will be exempted for the
presenter (free).
The final presentation format and schedule be informed by email to each author at the latest by • Please contact secretariat for the free registration
August 1st, 2021. The presentation schedule will be only provided for those presenters that have paid the • Failure to comply with the rules will result in disqualification. No exceptions will be granted.
registration fee. • Pre-recorded video should be submitted at last on August 25th 2021 by clicking and follow the
instruction steps at :
http://203.77.239.230/submit_video/eposter_asmiua/index.php/auth_peserta
(Email and password VirConEx/Registration)
28 29
UNMODERATED E-POSTER PRESENTATION
GUIDELINE REGISTRATION INFORMATION
REGISTRATION FEE
• All participants who are not accepted in oral / moderated e-poster session are welcomed to submit All participants including Free Paper Presenters must register for the meeting. Registration is valid
e-poster versions of their submitted abstracts when the committee has received the registration form and respective payments. To register, please
• E-Poster will be titled as unmoderated poster should it is not chosen for moderated oral / moderated complete the registration form and paid through available payment method via Online Registration at
e-poster presentation www.asmiua2021.org.
• E-poster will be published and exhibited during ASMIUA 2021 main congress
• One poster will be awarded “Best Unmoderated Poster” For more information please contact the secretariat at following email asmiua2021@pharma-pro.com
• Registration to ASMIUA is a compulsory for the participants. 50% discount for ASMIUA’s registration
will be given for 1 author for each poster. REGISTRATION CANCELATION
• Please contact secretariat for registration. No refund will be provided for Registration Cancelation.
• Poster should be submitted at last on August 17th 2021 by clicking and follow the instruction steps
at :
https://reg.pharma-pro.co.id/eposter/asmiua2021/insert.php
(Email and password VirConEx/Registration)
E-Poster Guidelines
No specific format for the poster content or design, however please provide :
• Title
• Name & Affiliation (bold the corresponding author)
• Background & Aim
• Method
• Result and Discussion
• Conclusion
• References
30 31
FORM REGISTRATION SPONSORS
44th ANNUAL SCIENTIFIC MEETING OF INDONESIAN UROLOGICAL ASSOCIATION
Urological Science and Services in the Era of Artificial Intelligence
Please Fill in This Form With Capital Block Letters DIAMOND
[ ] Prof. [ ] Dr. [ ] Mr. [ ] Ms.
Family Name
Given Name
Institution
Address
City Fax
Country
Phone Zip
Email
PLATINUM
SILVER
OTHER
32 33
34